MolDX: Melanoma Risk Stratification Molecular Testing - Effective December 06, 2020

This Local Coverage Determination (LCD) has completed the Open Public Meeting and comment period and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV). Responses to comments received may be found as a link at the bottom of the final LCD.

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L37750
LCD Title: MolDX: Melanoma Risk Stratification Molecular Testing
FORMERLY: MolDX: DecisionDx-Melanoma
Effective Date: December 06, 2020
Summary of LCD: Molecular diagnostic tests used to assist in risk stratification of melanoma patients.

Visit the Future LCDs webpage to access this LCD.

            Last Updated Thu, 22 Oct 2020 17:33:38 +0000